Hematologija
Lečenje i kontrola hemostaze
Rekombinovani aktivirani faktor VII (rFVIIa)
Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura. (otvara novi prozor)
Izvor: Br J Haematol 2003;120(5):909-10.
Indeks: PubMed 12614230
https://www.ncbi.nlm.nih.gov/pubmed/12614230 (otvara novi prozor)
Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. (otvara novi prozor)
Izvor: Am J Hematol 2002;69(3):219-22.
Indeks: PubMed 11891811
https://www.ncbi.nlm.nih.gov/pubmed/11891811 (otvara novi prozor)
Life-threatening retro-pharyngeal bleed in a case of systemic lupus erythematosus--an uncommon but important evil of a common disease. (otvara novi prozor)
Izvor: BMJ Case Rep 2011;2011:bcr0820114627.
Indeks: PubMed 22675012
DOI: 10.1136/bcr.08.2011.4627
https://www.ncbi.nlm.nih.gov/pubmed/22675012 (otvara novi prozor)
Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature. (otvara novi prozor)
Izvor: Ann Hematol 2009;88(1):11-5.
Indeks: PubMed 18787824
DOI: 10.1007/s00277-008-0608-3
https://www.ncbi.nlm.nih.gov/pubmed/18787824 (otvara novi prozor)
The use of recombinant factor VIIa in a Jehovah's Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage. (otvara novi prozor)
Izvor: Br J Haematol 2002;119(1):286-8.
Indeks: PubMed 12358947
https://www.ncbi.nlm.nih.gov/pubmed/12358947 (otvara novi prozor)